Introduction
In comparison with all other breast magnetic resonance imaging (MRI) techniques, dynamic contrast-enhanced MRI (DCE-MRI) and apparent diffusion coefficient (ADC) calculated using diffusion-weighted MRI (DW-MRI) are the most widely used [1, 2] . However, the overlaps of DCE-MRI and ADC in malignant and benign breast lesions indicate that neither is as such the best tool for diagnosing breast lesions [3] [4] [5] [6] . Intravoxel incoherent motion (IVIM) imaging has been applied for the characterization of breast cancer and discrimination between breast cancer and benign breast lesions [7, 8] ; however, so far, it has not been shown whether IVIM alone or combined with DCE-MRI or DW-MRI could provide better diagnostic accuracy than DCE-MRI or DW-MRI alone.
The purpose of this study was to retrospectively compare the IVIM parameters obtained with multi-b-values on benign and malignant breast masses and to determine whether these parameters alone or combined with DCE-MRI or DW-MRI can distinguish between malignant and benign breast masses with higher accuracy compared to conventional DCE-MRI and DW-MRI alone or combined models.
Patients and Methods

Study Population
This retrospective study was approved by our institutional review board. Written consent was obtained from all subjects before scans were performed. A review of our MRI database was performed to identify eligible patients who underwent breast MRI from February 10, 2012 to August 15, 2013 .
Inclusion and Exclusion Criteria
Breast MRI was performed prior to biopsy or surgery. Lesions with any of the following features were excluded from the study: non-mass, non-enhancement, preoperative biopsy, neoadjuvant chemotherapy, and radiation therapy. A total of 23 benign masses (21 women) and 31 malignant masses (27 women)
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were included in the study. The mean age of the patients was 46.85 ± 8.63 years. Benign masses included fibroadenoma (n = 22) and papilloma (n = 1). Malignant masses included invasive ductal carcinoma (n = 28), ductal carcinoma in situ (n = 1), and mixed pathology (invasive ductal carcinoma and ductal carcinoma in situ, n = 2). All 31 malignant masses and 20 of the benign masses were confirmed by surgical pathology. The remaining 3 benign masses were confirmed by ultrasound-guided needle biopsy. A total of 7 lesions were excluded based on the exclusion criteria: 6 non-mass-like enhanced lesions in 5 patients and 1 lesion in a patient with neoadjuvant chemotherapy.
MRI Acquisition
All MRI examinations were performed with a 3.0T imager (GE Signa HDX; GE Healthcare, Milwaukee, WI, USA) by means of a bilateral 8-channel phased array coil (Sentinelle Medical, Toronto, Canada). The images were acquired in axial orientation and in the following order: T2-weighted fast spin echo sequence, T1-weighted non-fat-suppressed sequence, DW sequence, IVIM sequence, and finally 3-dimensional T1-weighted fat-suppressed DCE sequence.
Imaging parameters of DCE-MRI were as follows: repetition time/echo time = 4.1/2.1 ms, field of view = 28 cm, nex = 0.71, matrix = 300 × 300, slice thickness = 1.2 mm, gap = 0 mm. The images were obtained with 6 postcontrast acquisitions centered at 40, 120, 200, 280, 360, and 440 s. Gadopentetate dimeglumine (Magnevist; Bayer Healthcare, Berlin, Germany) was injected intravenously as a bolus (0.1 mmol/kg body weight) by a power injector at 2 ml/s, followed by a 20 ml saline flush.
Imaging parameters of DW-MRI were as follows: frequency-selective fat saturation, parallel acquisition factor = 2.0, repetition time/echo time = 2,500/88.2 ms, field of view = 28 cm, nex = 2, matrix = 128 × 128, slice thickness = 6.0 mm, gap = 1 mm. b-values were 0 and 1,000 s/mm 2 . The scan time was 45 s. Imaging parameters of IVIM were as follows: frequency-selective fat saturation, parallel acquisition factor = 2.0, repetition time/echo time = 2,000/85 ms, field of view = 28 cm, nex = 4, matrix = 128 × 128, slice thickness = 6 mm, gap = 1 mm. 10 b-values were used: 0, 10, 20, 50, 100, 200, 300, 400, 600, 800 s/mm 2 . The total scan time was 226 s.
Image Analysis
All images were transferred to a processing workstation (ADW 4.3; GE Healthcare) and interpreted by 2 radiologists in a consensus-oriented way. Each lesion was assigned to the 2 radiologists who did not know the histopathologic outcomes. The initial enhancement ratio (IER) and time-signal intensity curve (TIC) were measured and calculated on DCE images. The ADC 0,1000 value was derived from the ADC maps of DWI with b = 0 and 1,000 s/mm 2 . Values of D, D*, and f were acquired on IVIM images. The ADC 50,800 value was derived from the ADC maps of DWI with b = 0 and 800 s/mm 2 calculated from the IVIM images.
According to the DCE images of the 3rd (2nd postcontrast) series, the slice which showed the maximum transverse diameter of a lesion was chosen and a region of interest (ROI) was manually placed on the most enhancing portion of the lesion. The signal intensity (SI) between the 1st (precontrast) and the 3rd DCE series was calculated and referred to as IER (%). The TIC was categorized into 3 types based on the percentage change of SI between the 3rd (2nd postcontrast) and the 7th (last postcontrast) DCE series with a 5% cutoff range [9] : Type I, persistent pattern (percentage increase of SI > 5%); Type II, plateau pattern (deviation of percentage increase of SI between +5% and -5%); and Type III, washout pattern (percentage decrease of SI > 5%). The DCE ROI was copypasted into the DWI image. The ADC value was acquired as the mean value of voxels in ROI on ADC maps with the formula described in previous reports [10] . For IVIM, 3 diffusivity values were set as follows: the diffusion coefficient of slow or non-perfusion-related molecular diffusion (D, × 10 -3 mm 2 /s), which represents true molecular diffusion; the diffusion coefficient of fast or perfusion-related diffusion-based diffusion (D*, × 10 -3 mm 2 /s), which represents perfusion-related diffusion; and the perfusion-related diffusion fraction (f, %), which represents the fractional volume occupied in the voxel by flowing spins. The calculation of D, D*, and f was performed with the research software Multiple ADC (MADC) with the formula described in previous studies [11, 12] . The DCE ROI was also copy-pasted into the IVIM images. The radiologists responsible for measurement would manually adjust the ROI on IVIM images in order to avoid going beyond the outline of the lesion.
Statistical Analysis
The one-sample Kolmogorov-Smirnov test was first used to analyze continuous variables for normality. Continuous variables with normal distribution were expressed as mean ± standard deviation (SD). The Student's unpaired t test and χ 2 test were applied to estimate the differences in continuous variables and enumeration variables between group pairs. Univariate and multivariate logistic regression models were performed to identify indictors that optimally discriminated malignant from benign lesions, and the diagnostic accuracy of these indicators was evaluated in terms of sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve (AUC a Unless otherwise indicated, continuous data are presented as the mean ± standard deviation. DCE-MRI = Dynamic contrast-enhanced magnetic resonance imaging; IER = initial enhancement ratio; TIC = time-signal intensity curve; DW-MRI = diffusion-weighted magnetic resonance imaging; ADC = apparent diffusion coefficient; IVIM = intravoxel incoherent motion; D = tissue diffusivity; D* = pseudodiffusivity; f= perfusion fraction. 
Results
Features of Benign and Malignant Masses on DCE, DW, and IVIM Images
The mean ROI area of benign masses was 87.5 mm 2 (range 55.3-189.7 mm 2 ). The mean ROI area of malignant masses was 159.9 mm 2 (range 82.6-243. 
Discrimination of Malignant Masses with Univariate Modeling
Univariate logistic regression showed that D, TIC Type II and III, and IER provided the most accurate discrimination between malignant and benign masses, followed by ADC 50,800 , ADC 0,1000 , D*, and f. The individual indicators for discrimination of malignant masses of DEC-MRI, DW-MRI, and IVIM are shown in the online supplementary table (www.karger.com/?DOI=447765).
Discrimination of Malignant Masses with Multivariate Modeling
Stepwise multivariate analysis of univariate discriminators (IER, TIC, ADC, D, D*, and f) identified D and TIC as the significant independent predictors of malignant masses (p = 0.007 and 0.038, respectively). The combined models for discrimination of malignant masses are displayed in the online supplementary table (www.karger. com/?DOI=447765). Figure 3 shows multiple comparisons of ROC curves of individual and combined models. The curves of the 3 combined models were significantly or marginally significantly higher than those of TIC or ADC alone (p = 0.004-0.069). However, there was no significant difference between the 3 combined models and no significant difference between D and the 3 combined models (all p > 0.05). 
Discussion
Our study revealed that D of IVIM has the highest diagnostic accuracy in differentiating malignant from benign breast masses among all the individual imaging indicators. The combination of D and TIC maximized the AUC to that achievable with other combined models.
Our results showed that compared with conventional ADC of DW-MRI, D significantly improved diagnostic accuracy in the characterization of breast masses. In principle, the histologic characteristics reflected by D of IVIM are similar to those of ADC of DWI; however, D should be superior to ADC because it can demonstrate more precisely the true diffusion without influence of perfusion-related diffusion [13] . Although our results confirmed the superiority of D over ADC once again in clinical practice, the extent of this superiority should be further researched given the heterogeneity of ADC in terms of sensitivity and specificity between our study and previous studies [6] . An optimal pair of bvalues used in conventional DW-MRI may be able to decrease the superiority of D over ADC. As with most previous studies [14] , we used a pair of 0 and 1,000 s/mm 2 as the b-values in the conventional breast DW-MRI. Some studies indicated that 50 s/mm 2 and 800 or 1,000 s/mm 2 may be the more optimized low and high bvalues in conventional breast DW-MRI on 3.0T MRI [14, 15] . To test whether these potentially optimized b-values (50 and 800 s/ mm 2 ) can lead to a better result similar to IVIM compared to our current b-values (0 and 1,000 s/mm 2 ), images of b = 50 and b = 800 s/mm 2 from IVIM were selected to calculate the ADC 50,800 maps. Our results showed that both the ADC 0,1000 and ADC 50,800 were inferior to the D of IVIM in discriminating malignant from benign breast lesions. However, it should be noted that ADC 50,800 presented higher AUC and specificity values than ADC 0,1000 , although both had the same sensitivity values. Thus, the b-values 50 and 800 s/mm 2 may be better suited than 0 and 1,000 s/mm 2 in conventional breast DW-MRI on 3.0T MRI.
In the present study, the mean D* value of benign breast masses was higher than that of malignant masses. Compared with ADC, D* cannot further increase the diagnostic sensitivity and specificity. This may be related to the varying tumor vascularity among different masses [7] . In our study, the mean f value of benign breast masses was lower than that of malignant ones, and f could further increase the diagnostic sensitivity compared with ADC, although the AUC value of f was the lowest in the present study. Compared with another breast IVIM study by Liu et al. [7] , in our study the mean D* value and f value for both benign and malignant breast lesions were relatively lower. This may be due to the different quantity and distribution of low and high b-values used in IVIM.
Multiparametric MRI of the breast can provide unique information about breast lesions and therefore has the potential to significantly improve breast cancer diagnosis [2] . In the present study, we assessed the diagnostic efficiency of combined multiparametric data by comparing 3 combined models: D and ADC (both ADC 0,1000 and ADC 50,800 ), TIC and ADC (both ADC 0,1000 and ADC 50,800 ), D and TIC. Our results showed that there was no significant difference between the 3 combined models, even though the combination of D and TIC maximized the AUC to that achievable with other combined models. However, both sensitivity and specificity of the 3 combined models were significantly or marginally significantly higher than that of TIC or ADC alone, which once again illustrates the importance of multiparametric MRI in breast imaging. Therefore, the combined model of D and TIC has the highest diagnostic value compared with any individual or combined parameters.
Our work has some limitations. Firstly, this was a preliminary and single-center study; besides, the patient samples were of insufficient size. Secondly, the appropriate number of b-values for breast IVIM are still unknown. Considering that the b-value scheme strongly affects the IVIM parameters [16] , it should be further evaluated for the most appropriate IVIM in cancer diagnosis. Finally, the histologic distribution of benign and malignant breast lesions was narrowed due to the inclusion criteria. The main aim of the present study was to determine whether the IVIM parameters alone or combined with DCE-MRI and DW-MRI can differentiate malignant from benign breast lesions with higher accuracy and to compare the diagnostic value of different multiparametric models. Hence, non-mass-like enhanced breast lesions were not included in our study given that their most important diagnostic features are distribution and internal enhancement pattern but not functional (such as DCE) or molecular (DWI) MRI [13] .
In conclusion, according to our study, D of IVIM can effectively complement existing conventional DCE-MRI and DW-MRI in differentiating malignant from benign breast masses. In addition, using D of IVIM in conjunction with DCE-MRI can produce a robust means of evaluating benign and malignant breast masses. 
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